ArticleInflammatory intestinal diseases2018

Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study.

Tadashi Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.